It's nice to see the Clearside Biomedical, Inc. ( NASDAQ:CLSD ) share price up 13% in a week. But that doesn't ...

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.

ALPHARETTA, Ga., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®) ...

Ondine Biomedical, Inc. (GB:OBI) has released an update. Ondine Biomedical Inc., a Canadian life sciences company, has successfully raised C$16.2 million through an upsized funding round to ...

Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling ...

Ondine Biomedical, Inc. (GB:OBI) has released an update. Ondine Biomedical Inc., a Canadian life sciences company, is set to raise at least £8.5 million through a fundraising initiative involving ...

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - ...

ALPHARETTA, Ga. - Clearside Biomedical, Inc. (NASDAQ:CLSD), a company focused on developing treatments for eye diseases, announced the appointment of Tony Gibney as Chair of its Board of Directors ...

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.23 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.24 per share a year ago.